subject area of
- In vitro disintegration studies of weekly generic and branded risedronate sodium formulations available in Canada Academic Article
- A reappraisal of generic bisphosphonates in osteoporosis Academic Article
- Adverse events, bone mineral density and discontinuation associated with generic alendronate among postmenopausal women previously tolerant of brand alendronate: a retrospective cohort study Academic Article
- Antihypertensive treatment – navigating between cost, compliance and complications Academic Article
- Are Brand-Name and Generic Warfarin Interchangeable? Multiple N-of-1 Randomized, Crossover Trials Academic Article
- Brand Name versus Generic Warfarin: A Systematic Review of the Literature Academic Article
- Canada’s New Generic Pricing Policy: A Reasoned Approach to a Challenging Problem Academic Article
- Canada’s laws on pharmaceutical intellectual property: the case for fundamental reform: Figure 1: Academic Article
- Could patents interfere with the development of a cardiovascular polypill? Academic Article
- Efficacy of substituting innovator propafenone for its generic formulation in patients with atrial fibrillation Academic Article
- Establishing Therapeutic Equivalence of Complex Pharmaceuticals: The Case of Dabigatran Academic Article
- Examining therapeutic equivalence between branded and generic warfarin in Brazil: The WARFA crossover randomized controlled trial Academic Article
- Factors associated with drug shortages in Canada: a retrospective cohort study Academic Article
- Generic immunosuppression in solid organ transplantation: systematic review and meta-analysis Academic Article
- Global access to affordable direct oral anticoagulants Academic Article
- Maximising access to achieve appropriate human antimicrobial use in low-income and middle-income countries Academic Article
- Modeling Tiered Pricing Frameworks: A Simulation Approach Academic Article
- Perceptions of the population regarding generic drugs in Brazil: a nationwide survey Academic Article
- Pharmacists’ views and reported practices in relation to a new generic drug substitution policy in Lebanon: a mixed methods study Academic Article
- Prescription Drug Shortages: Impact on Neonatal Intensive Care Academic Article
- Strategies to Reduce Out-of-Pocket Medication Costs for Canadians Living with Heart Failure Academic Article
- Symptom relapse following switch from Celexa to generic citalopram: an anxiety disorders case series Academic Article
- The Impact of Reference Pricing of Nonsteroidal Anti-Inflammatory Agents on the Use and Costs of Analgesic Drugs Academic Article
- The Impact of Tiered-Pricing Framework on Generic Entry in Canada Academic Article
- The United States Food and Drugs Administration Approves a Generic Enoxaparin Academic Article
- Trends and uptake of new formulations of controlled‐release oxycodone in Canada Academic Article
- US drug shortages compared to the World Health Organization’s Model List of Essential Medicines for Children: A cross-sectional study Academic Article